Related Experiment Video
Updated: Oct 12, 2025

Cell Type-specific Gene Expression Profiling in the Mouse Liver
Published on: September 17, 2019
Investigation of Ifosfamide Toxicity Induces Common Upstream Regulator in Liver and Kidney
Hyoung-Yun Han1,2, Mi-Sun Choi1,3, Seokjoo Yoon1,2
1Department of Predictive Toxicology, Korea Institute of Toxicology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Korea.
Abstract:
Ifosfamide is an alkylating agent, a synthetic analogue of cyclophosphamide, used to treat various solid cancers. In this study, the toxicity of ifosfamide was evaluated using single-and multiple-dose intraperitoneal administration in rats under Good Laboratory Practice guidelines, and an additional microarray experiment was followed to support toxicological findings. A single dose of ifosfamide (50 mg/kg) did not induce any pathological changes. Meanwhile, severe renal toxicity was observed in the 7 and 28 days consecutively administered groups, with significant increases in blood urea nitrogen and creatinine levels. In the tox-list analysis, cholesterol synthesis-related genes were mostly affected in the liver and renal failure-related genes were affected in the kidney after ifosfamide administration. Moreover, interferon regulatory factor 7 was selected as the main upstream regulator that changed in both the liver and kidney, and was found to interact with other target genes, such as ubiquitin specific peptidase 18, radical S-adenosyl methionine domain containing 2, and interferon-stimulated gene 15, which was further confirmed by real-time RT-PCR analysis. In conclusion, we confirmed kidney-biased ifosfamide organ toxicity and identified identically altered genes in both the liver and kidney. Further comprehensive toxicogenomic studies are required to reveal the exact relationship between ifosfamide-induced genes and organ toxicity.
Insights
Ifosfamide causes severe kidney toxicity in rats after repeated doses, affecting cholesterol and kidney failure genes. Interferon regulatory factor 7 is a key regulator identified in liver and kidney tissues.
Area of Science:
- Toxicology
- Pharmacology
- Genomics
Background:
- Ifosfamide is a chemotherapy drug used for solid cancers.
- Understanding its toxicity is crucial for patient safety.
Purpose of the Study:
- To evaluate the toxicity of ifosfamide in rats.
- To identify molecular mechanisms of ifosfamide-induced toxicity using toxicogenomics.
Main Methods:
- Single and multiple dose intraperitoneal administration of ifosfamide in rats.
- Good Laboratory Practice (GLP) guidelines.
- Microarray analysis and real-time RT-PCR.
Main Results:
- Single ifosfamide dose (50 mg/kg) showed no toxicity.
- Repeated doses caused severe renal toxicity, with elevated blood urea nitrogen and creatinine.
- Gene expression analysis revealed affected cholesterol synthesis genes in the liver and renal failure genes in the kidney.
- Interferon regulatory factor 7 was identified as a key upstream regulator in both organs.
Conclusions:
- Ifosfamide exhibits kidney-biased toxicity.
- Identical gene expression alterations were observed in the liver and kidney.
- Further toxicogenomic studies are needed to clarify gene-toxicity relationships.
Related Concept Videos
Regulation of the Unfolded Protein Response
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hepatic Drug Excretion: Influencing Factors
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

